Clinical Trials for Complementary or Alternative Medicine Procedure(s)

Trials 51-61 of 61

  • Home-Based Neurofeedback Program in Treating Participants with Chemotherapy-Induced Peripheral Neuropathy

    This trial studies how well a home-based neurofeedback program works in treating participants with chemotherapy-induced peripheral neuropathy (nerve damage that affects motor function). Neurofeedback training is a type of therapy that uses an electroencephalograph and a computer software program to measure brain wave activity. It may help teach participants how to change their own brain waves to lower their perception of pain symptoms and improve overall quality of life.
    Location: M D Anderson Cancer Center, Houston, Texas

  • Hatha Yoga in Reducing Physical and Emotional Problems in Breast Cancer Survivors with or without Stage II-III Lymphedema

    This pilot clinical trial studies Hatha yoga in reducing physical and emotional problems in breast cancer survivors with or without stage II-III lymphedema. Yoga practices may benefit breast cancer survivors with lymphedema as they directly support lymph transport (postures, breathing, relaxation) and emotional well-being (relaxation, meditation).
    Location: Vanderbilt University / Ingram Cancer Center, Nashville, Tennessee

  • Acupuncture in Reducing Chemotherapy-Induced Peripheral Neuropathy in Patients with Stage I-III Breast or Gastrointestinal Cancer

    This pilot trial studies how well acupuncture works in reducing chemotherapy-induced peripheral neuropathy in patients with stage I-III breast or gastrointestinal cancer. Acupuncture may help reduce chemotherapy-induced peripheral neuropathy and improve quality of life.
    Location: Wake Forest University Health Sciences, Winston-Salem, North Carolina

  • Fluid Measurements and MRI in Determining Biomarkers of Lymphatic Dysfunction in Patients with Breast Cancer

    This trial uses fluid measurements of the arm and MRI to determine biomarkers of lymphatic dysfunction in patients with breast cancer. Studying the lymphatic system (the part of your body that helps to process and clear waste products) in different ways will help doctors understand more about lymphedema (excess fluid after lymph nodes are removed) and help with prevention and management of lymphedema in patients with breast cancer.
    Location: Vanderbilt University / Ingram Cancer Center, Nashville, Tennessee

  • A Multi-Modality Surveillance Program in Screening Women at High Risk for Breast Cancer

    The purpose of the Personalized Risk-based Imaging Surveillance Model (PRISM) study is to develop a personalized approach to screening women at high risk for breast cancer in diverse populations. A multi-modality surveillance program includes cognitive-behavioral self-management of anxiety therapy, clinical hypnosis, dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI), and mammogram. This study will also evaluate quality of life and measures of psychological well-being during breast cancer screening and compare breast MRI and mammogram in a high-risk population. Additionally, it will evaluate whether a new intervention for anxiety-reduction will help to improve adherence in high risk women undergoing intensive surveillance. Women participating in this study will learn self-management of anxiety using a technique called clinical hypnosis, which may help participants feel more relaxed during MRI. DCE MRI and mammogram may help doctors to detect breast cancer earlier when it is easier to treat.
    Location: University of Chicago Comprehensive Cancer Center, Chicago, Illinois

  • Tobacco Intervention Program in Improving Smoking Cessation in Patients at Risk for Lung Cancer

    This phase III trial studies how well a tobacco intervention program works in improving smoking cessation in patients who are at risk for lung cancer. Tobacco intervention program combines standard care nicotine replacement therapy with personalized messages and biomarker feedback that may help to stop and prevent future smoking in patients who have been screened or may be eligible for lung cancer screening.
    Location: 2 locations

  • mHealth in Aiding Participants in Smoking Cessation

    This early phase I trial studies how well mobile health (mHealth) works in aiding participating in quitting smoking. Mobile health for smoking cessation may better help doctors gather information and understand what happens when attempting to quit smoking.
    Location: Moffitt Cancer Center, Tampa, Florida

  • Brief Mind-Body Intervention in Reducing Pain and Anxiety in Patients Undergoing Prostate Needle Biopsy

    This pilot trial studies how well a brief mind-body intervention works in reducing pain and anxiety in patients who are undergoing prostate needle biopsy. The brief mind-body intervention involves mindfulness meditation which focuses on using positive images and breathing exercises that may lower the levels of pain, discomfort, and anxiety in patients prior to undergoing prostate needle biopsies.
    Location: Memorial Sloan Kettering Cancer Center, New York, New York

  • Cereset Intervention in Relieving Stress in Caregivers of Patients with High Grade Gliomas

    This trial studies how well the Cereset intervention works in relieving stress in caregivers of patients with high grade gliomas. Cereset is a stress-relaxation treatment where sounds are used that help to balance brain rhythms. The purpose of this study is to see if caregivers of patients with brain tumors will use the device and see how it might relieve stress and anxiety in caregivers.
    Location: Wake Forest University Health Sciences, Winston-Salem, North Carolina

  • Assessing the Levels of Chemotherapy-Induced Peripheral Neuropathy Using a Point-of-Nerve Conduction Device (NeuroMetrix) and the Rydel-Seiffer Tuning Fork in Patients Receiving Electroacupuncture Therapy

    This trial studies how well a point-of-care nerve conduction device (NeuroMetrix) and Rydel-Seiffer tuning fork work in assessing the levels of chemotherapy-induced peripheral neuropathy (CIPN) in patients receiving electroacupuncture therapy. CIPN is a common, persistent side effect among patients who receive chemotherapy. It is characterized by a variety of symptoms such as numbness, tingling, reduced sense of touch, reduced proprioception (awareness of limb and body position in space), pain, weakness, balance disturbances, and decreases in motor skills. Receiving electroacupuncture may have positive effects on CIPN. This trial may help researchers determine the validity of using NeuroMetrix and Rydel-Seiffer tuning fork in assessing the levels of CIPN in patients receiving electroacupuncture therapy.
    Location: Moffitt Cancer Center, Tampa, Florida

  • Music Therapy in Cancer Patients with Delirium

    This trial studies the use and experience of music therapy in cancer patients with delirium (a disturbance in mental abilities that results in confused thinking and reduced awareness) and the experience of music therapists working with these patients. Music therapy sessions are done at the patient’s bedside, where the music therapist plays live music on a guitar, keyboard, harp, or percussion instrument, sometimes as accompaniment to singing. Music therapy may improve physical and emotional symptoms such as pain, nausea, anxiety, and depression. Music therapy may also improve spiritual well-being and quality of life.
    Location: Memorial Sloan Kettering Cancer Center, New York, New York